SK

Sushil Khanna

Active Director Director DIN 01419591
DIN 01419591 First appointment Apr 2007 Primary industry Machinery and Equipment
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 2 historical roles
Total affiliations 3 Since Apr 2007
Shareholding value •••• Premium profile

About Sushil Khanna

Data last updated:

Sushil Khanna is a Director at Sika Interplant Systems Limited (since 2024). The companies operate in Machinery and Equipment, Healthcare and Pharma. Sika Interplant Systems Limited reported revenue of ₹216 Cr (FY 2026). Earlier, Sushil Khanna was a Nominee Director at Glaxosmithkline Asia Private Limited (2007–2012) and Director at Gsk Pharma India Private Limited (2009–2016).

DIN 01419591
Primary Designation Director
Industry Machinery and Equipment
First Appointment 01 Apr 2007
Oldest Company Age 40 yrs
Largest company Sika Interplant Systems Limited · ₹216 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sika Interplant Systems Limited L29190KA1985PLC007363
Director20 Sep 20241985₹216 Cr (FY 2026)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glaxosmithkline Asia Private Limited U99999PB1995PTC028476
Nominee Director01 Apr 20071995₹2,362 Cr (FY 2023)Active
Gsk Pharma India Private Limited U24239MH2000PTC126937
Director01 Sep 20092000₹31.87 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sushil Khanna

Directorship timeline

Open interactive timeline →
Sika Interplant Systems Limited
Glaxosmithkline Asia Private Limited
Gsk Pharma India Private Limited
Premium access

Shareholding and investment profile for Sushil Khanna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Khanna

Sushil Khanna currently holds 1 directorship: Sika Interplant Systems Limited (Director, since 20 Sep 2024, revenue ₹216 Cr (FY 2026)).

Sushil Khanna was first appointed on 01 Apr 2007 as Nominee Director at Glaxosmithkline Asia Private Limited. The most recent appointment on record is 20 Sep 2024 at Sika Interplant Systems Limited.

Sushil Khanna held 2 earlier board appointments: Glaxosmithkline Asia Private Limited (Nominee Director, 01 Apr 2007 to 27 Mar 2012); Gsk Pharma India Private Limited (Director, 01 Sep 2009 to 30 Nov 2016).

The current boards of Sushil Khanna's companies include Anuradha Sikka (Sika Interplant Systems Limited), Garimella Bhaskar Venkata Satya (Sika Interplant Systems Limited), Kendaganna Swamy Sathish (Sika Interplant Systems Limited), Kunal Sikka (Sika Interplant Systems Limited), Kunal Sikka (Sika Interplant Systems Limited), Parasuramachetty Jayapal (Sika Interplant Systems Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available